Search
Search Results
##search.searchResults.foundPlural##
-
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4633PDF: 1973HTML: 18065 -
THE BIOLOGY OF MYCOBACTERIUM TUBERCULOSIS INFECTION.
10808PDF: 6480HTML: 21912 -
INFECTIONS AND FOLLICULAR LYMPHOMA: IS THERE A LINK?
3304PDF: 1048HTML: 2280 -
MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA
2941PDF: 883HTML: 6600Untitled: 256Untitled: 209Untitled: 232Untitled: 238 -
-
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
1351PDF: 481HTML: 18620Figure 1: 179Figure 2: 160Figure 3: 177Figure 4: 215Figure 5: 188 -
PATHOGENESIS AND TREATMENT OF THROMBOHEMORRHAGIC DIATHESIS IN ACUTE PROMYELOCYTIC LEUKEMIA
1878PDF: 841HTML: 10345Figures 1,2,3: 206 -
THE ROLE OF INFECTION IN THE PATHOGENESIS OF VASO-OCCLUSIVE CRISIS IN PATIENTS WITH SICKLE CELL DISEASE.
5282PDF: 1366HTML: 2863Cover letter: 216 -
BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS MESENCHYMAL STEM CELL IN T-MN
1916PDF: 1027HTML: 219 -
SICKLE CELL DISEASE AND VENOUS THROMBOEMBOLISM
2316PDF: 926HTML: 2201 -
GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS
2648PDF: 832HTML: 5361 -
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2679PDF: 1657HTML: 2441Table1: 206 -
ROLE OF CYTOKINES AS MOLECULAR MARKER OF DENGUE SEVERITY
3252PDF: 1199HTML: 486 -
THE GUT MICROBIOTA AND IMMUNE SYSTEM RELATIONSHIP IN HUMAN GRAFT-VERSUS-HOST DISEASE
6440PDF: 2179HTML: 14139Untitled: 213figure: 199 -
-
Routine inflammatory markers are elevated in myelodysplastic syndromes at presentation Inflammatory marker elevation in MDS
925PDF: 700HTML: 249 -
-
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3833PDF: 1625HTML: 829Figures . Eliassian: 240 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3665PDF: 2575HTML: 1563 -
-
THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition
1439PDF: 892HTML: 230 -
LYMPHOCYTES IN PATIENTS WITH CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1 EXPRESSION AND A PREVAILING TH2 IMMUNE RESPONSE. EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1
2937PDF: 1130HTML: 126 -
EVALUATION OF THE PLASMA MICRO RNA EXPRESSION LEVELS IN SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS
1436PDF: 718HTML: 1184Untitled: 195Untitled: 160Untitled: 145Untitled: 164Untitled: 174 -
NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL
2604PDF: 871HTML: 9052Efremov 1: 249Efremov 2: 211 -
IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS
3131PDF: 903HTML: 7293Kost Fig1: 206Kost Fig 2: 194Kost Fig3: 196Kost Fig 4: 209Kost Fig5: 209Kost fig 6: 194 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1466PDF: 844HTML: 3129 -
THE PROTHROMBOTIC STATE ASSOCIATED WITH SARS-COV-2 INFECTION: PATHOPHYSIOLOGICAL ASPECTS COVID and Thrombosis
2209PDF: 841HTML: 443 -
NEW THERAPEUTIC OPTIONS FOR THE TREATMENT OF SICKLE CELL DISEASE Guest Editor: Raffaella Origa
7049PDF: 3729HTML: 812 -
PEDIATRIC MASTOCYTOSIS: AN UPDATE Chldren' Mastocytosis
1932HTML: 1635PDF: 1138 -
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2249PDF: 1787HTML: 824 -
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1635PDF: 1083HTML: 429 -
RECENT ADVANCES IN THE 5Q- SYNDROME
2885PDF: 1864HTML: 3789Pellagatti Fig 1: 235Pellagatti Fig. 2: 230 -
PATHOBIOLOGY OF HODGKIN LYMPHOMA
3331PDF: 1494HTML: 5960Fig1-Ag-Pil: 250Ag-Pil Fig.2: 250 -
-
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4537PDF: 1759HTML: 1171







